Advertisement
Advertisement

MCK

MCK logo

McKesson Corporation

727.65
USD
-3.15
-0.43%
Jun 13, 15:59 UTC -4
Closed
exchange

After-Market

727.64

0.00
0.00%

McKesson Corporation Profile

About

McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.

Info & Links

CEO

Brian S. Tyler

Headquarters

6555 STATE HIGHWAY 161
IRVING, TX 75039, UNITED STATES

Sector

Medical

Auditor

Deloitte & Touche LLP

Share holders

3,895

Employees

45,000

McKesson Corporation Statistics

Valuation Measures

Market Capitalization2

90.96B

Enterprise Value

96.52B

Enterprise Value/EBITDA(ttm)

19.08

Price to Earnings Ratio(ttm)

20.70

Price to Sales(ttm)

0.22

Price to Book(mrq)

--

Price to Cash(ytd)

18.38

Profitability

Gross Margin(ttm)

3.72%

Operating Margin(ttm)

1.09%

Profit Margin(ttm)

0.93%

Return on Equity(ttm)

-181.26%

Return on Invested Capital(ttm)

40.87%

Return on Assets(ttm)

5.34%

Income Statement

Revenue(ttm)

359.05B

Revenue Per Share(ttm)

2.87K

Gross Profit(ttm)

13.32B

EBITDA(ttm)3

5.06B

Net Income Available to Common(ttm)

3.29B

Diluted EPS(ttm)

21.84

Share Statistics

Beta (5Y Monthly)

0.52

52-Week Change

23.34%

S&P 500 52-Week Change

9.20%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

125.11M

Dividend Yield

0.47%

Float4

125.19M

% Held by Insiders

0.11%

% Held by Institutions

85.07%

Balance Sheet

Total Cash(mrq)

5.69B

Total Cash Per Share(mrq)

45.49

Total Debt(mrq)

11.26B

Total Debt/Equity(mrq)

-664.40%

Current Ratio(mrq)

0.90%

Quick Ratio(mrq)

0.48%

Book Value Per Share(mrq)

-13.55

Cash Flow

Operating Cash Flow Per Share(ytd)

47.50

Free Cash Flow(ytd)

5.23B

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement